New research identifies promising drug combination for multiple myeloma treatment
More information: Lyndsey Flanagan et al, Steroid-free combination of 5-azacytidine and venetoclax for the treatment of ...
mskcc.org9y
Treatment for Myelodysplastic Syndrome (MDS)
The US Food and Drug Administration approved 5-azacytidine for the treatment of MDS in 2004. The drug improves bone marrow function by freeing up the genes the body needs to make normal blood cells.
News Medical on MSN11mon
Venetoclax combo opens new treatment path for incurable multiple myeloma
By combining venetoclax and 5-azacytidine we've seen enhanced efficacy across a wide range of patient samples. It shows the ...